HIV Management Today

Assessing and Acting on Cardiovascular Disease Risk in HIV-Infected Patients

A Podcast Discussion With Marshall Glesby, M.D., Ph.D., and Jens Lundgren, M.D.

Over the past few years, the HIV clinical realm has seen an increased focus on the constellation of events that are associated with cardiovascular disease. In many ways, our understanding of cardiovascular risk in HIV-infected patients is still in its infancy. There remains a fair amount of uncertainty not only regarding the HIV- or antiretroviral-specific factors that increase this risk, but also regarding the strategies to employ in an effort to prevent, assess or manage the dangers of cardiovascular disease in people with HIV. But there is a lot we do know, and that knowledge can help guide clinicians as they determine the best way forward.

To discuss these issues, we brought together two of the leading minds on cardiovascular disease and HIV for a frank conversation: Marshall Glesby, M.D., Ph.D., the associate chief of the Division of Infectious Diseases and the director of the Cornell HIV Clinical Trials Unit at Weill Cornell Medical College; and Jens Lundgren, M.D., the chief physician and director of the Copenhagen HIV Programme. Both are at the forefront of research efforts in this area.

Marshall Glesby, M.D., Ph.D.Jens Lundgren, M.D.
Marshall Glesby, M.D., Ph.D.Jens Lundgren, M.D.

Download Audio

Copyright © 2010 The HealthCentral Network, Inc. All rights reserved.